GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yabao Pharmaceutical Group Co Ltd (SHSE:600351) » Definitions » Gross-Profit-to-Asset %

Yabao Pharmaceutical Group Co (SHSE:600351) Gross-Profit-to-Asset % : 45.47% (As of Mar. 2024)


View and export this data going back to 2002. Start your Free Trial

What is Yabao Pharmaceutical Group Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Yabao Pharmaceutical Group Co's annualized Gross Profit for the quarter that ended in Mar. 2024 was ¥1,740 Mil. Yabao Pharmaceutical Group Co's average Total Assets over the quarter that ended in Mar. 2024 was ¥3,825 Mil. Therefore, Yabao Pharmaceutical Group Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 45.47%.


Yabao Pharmaceutical Group Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Yabao Pharmaceutical Group Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yabao Pharmaceutical Group Co Gross-Profit-to-Asset % Chart

Yabao Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 42.27 37.02 41.63 37.01 42.17

Yabao Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.04 39.61 37.35 44.25 45.47

Competitive Comparison of Yabao Pharmaceutical Group Co's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Yabao Pharmaceutical Group Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yabao Pharmaceutical Group Co's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Yabao Pharmaceutical Group Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Yabao Pharmaceutical Group Co's Gross-Profit-to-Asset % falls into.



Yabao Pharmaceutical Group Co Gross-Profit-to-Asset % Calculation

Yabao Pharmaceutical Group Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=1683.423/( (4131.067+3853.637)/ 2 )
=1683.423/3992.352
=42.17 %

Yabao Pharmaceutical Group Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=1739.5/( (3853.637+3797.111)/ 2 )
=1739.5/3825.374
=45.47 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Yabao Pharmaceutical Group Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Yabao Pharmaceutical Group Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Yabao Pharmaceutical Group Co (SHSE:600351) Business Description

Traded in Other Exchanges
N/A
Address
No.43 Fumin Road, Ruicheng, Shanxi Province, Yuncheng, CHN, 044602
Yabao Pharmaceutical Group Co Ltd is engaged in the manufacture and operation of western and Chinese medicines, APIs, health care products, packing materials for medicine, and also engages in the planting and processing of medicinal herbs.

Yabao Pharmaceutical Group Co (SHSE:600351) Headlines

No Headlines